The S100B story: from biomarker to active factor in neural injury

Journal of Neurochemistry
Fabrizio MichettiMaria Concetta Geloso

Abstract

S100B is a Ca2+ -binding protein mainly concentrated in astrocytes. Its levels in biological fluids (cerebrospinal fluid, peripheral and cord blood, urine, saliva, amniotic fluid) are recognized as a reliable biomarker of active neural distress. Although the wide spectrum of diseases in which the protein is involved (acute brain injury, neurodegenerative diseases, congenital/perinatal disorders, psychiatric disorders) reduces its specificity, its levels remain an important aid in monitoring the trend of the disorder. Mounting evidence now points to S100B as a Damage-Associated Molecular Pattern molecule which, when released at high concentration, through its Receptor for Advanced Glycation Endproducts, triggers tissue reaction to damage in a series of different neural disorders. This review addresses this novel scenario, presenting data indicating that S100B levels and/or distribution in the nervous tissue of patients and/or experimental models of different neural disorders, for which the protein is used as a biomarker, are directly related to the progress of the disease: acute brain injury (ischemic/hemorrhagic stroke, traumatic injury), neurodegenerative diseases (Alzheimer's disease, Parkinson's disease, amyotrophic lateral ...Continue Reading

References

Jan 1, 1992·Neurobiology of Aging·D R MarshakW S Griffin
Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J BaudierJ J Lawrence
Aug 1, 1990·Journal of the Neurological Sciences·O S JørgensenR Balázs
Jan 1, 1990·Acta Neuropathologica·F MichettiL Lauriola
May 21, 1990·Brain Research·E C AzmitiaP M Whitaker-Azmitia
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W S GriffinC Araoz
Nov 6, 1989·FEBS Letters·E V Skripnikova, N B Gusev
Jan 1, 1985·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·L LauriolaD Cocchia
Dec 15, 1987·Brain Research·L J Van Eldik, D B Zimmer
Oct 1, 1986·Cell Biology International Reports·F MichettiD Cocchia
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D Kligman, D R Marshak
Jan 1, 1985·Cell and Tissue Research·F MichettiD Cocchia
Jun 9, 1965·Biochemical and Biophysical Research Communications·B W Moore
Nov 1, 1984·Journal of Neurochemistry·F SuzukiT Nakajima
Sep 1, 1983·Journal of Biochemistry·K KatoT Nakajima
Jun 1, 1984·Journal of Neurochemistry·V E ShashouaB W Moore
Jan 7, 1982·Nature·K StefanssonB G Arnason
Jan 1, 1982·Cell and Tissue Research·F Michetti, D Cocchia
Jan 1, 1980·Journal of the Neurological Sciences·F MichettiG Rigon
Jun 16, 1995·The Journal of Biological Chemistry·V V IvanenkovR V Dimlich
May 1, 1995·Progress in Neurobiology·G FanòP Calissano
Aug 1, 1995·Neuroscience·M Rickmann, J R Wolff
Sep 29, 1994·Biochimica Et Biophysica Acta·L J Van Eldik, W S Griffin
Oct 1, 1993·Melanoma Research·A J CochranD R Wen
May 1, 1993·Journal of Neuropathology and Experimental Neurology·K L GoodisonA W Clark
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H B GuoD Klingmüller
Apr 18, 1996·Nature·J HeierhorstB E Kemp
Mar 1, 1996·Journal of Neuropathology and Experimental Neurology·R E MrakW S Griffin

❮ Previous
Next ❯

Citations

Dec 31, 2019·Human & Experimental Toxicology·Amal Saf Hafez, Ghada N El-Sarnagawy
Feb 23, 2020·International Journal of Molecular Sciences·Aristo VojdaniDatis Kharrazian
Oct 3, 2020·Journal of Autism and Developmental Disorders·Zhen ZhengXiaobing Zou
Mar 3, 2020·Frontiers in Pharmacology·Vadim V TarasovGjumrakch Aliev
Jun 4, 2019·Frontiers in Neuroscience·Kai-Ge LiangYao-Jiang Huang
Jul 30, 2020·Cancers·Chantal AllgöwerJohannes Lemke
Nov 15, 2018·BioMed Research International·Yuzhen WeiLinlin Yin
Mar 7, 2020·Fluids and Barriers of the CNS·Richard F KeepLester R Drewes
Nov 13, 2018·Frontiers in Cellular Neuroscience·Elisa MarcheseMaria Concetta Geloso
Aug 28, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P PerrinS Caillard
Nov 26, 2020·Pathogens and Disease·Thekra KhushafaZhu Haixia
Dec 7, 2020·Revista brasileira de anestesiologia·André P Schmidt, Maria José C Carmona
Dec 7, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Valentina BellissimaDiego Gazzolo
Feb 2, 2021·Data in Brief·Jaspreet Kaur, Eller Conti
Oct 31, 2020·Scientific Reports·Antonio AcetiFabrizio Michetti
Dec 16, 2020·Journal of Neuroinflammation·Pia GrotegutStephanie C Joachim
Dec 10, 2020·International Journal of Molecular Sciences·Victoria S ArmstrongOliver F Bathe
Feb 17, 2021·Nature Neuroscience·Carole EscartinAlexei Verkhratsky
Feb 18, 2021·Reviews in the Neurosciences·Sara MomtazmaneshNima Rezaei
Jan 14, 2020·Physiological Research·A TomovaD Ostatníková
Oct 15, 2020·Cellular and Molecular Life Sciences : CMLS·Efthalia AngelopoulouChristina Piperi
Mar 24, 2021·Nordic Journal of Psychiatry·Bürge Kabukçu BaşaySezai Üstün Aydin
Apr 6, 2021·Current Opinion in Toxicology·Ayse Basak EnginAtilla Engin
Apr 23, 2021·Structure·Alexander MoysaMichal Dadlez
May 1, 2021·Pharmaceuticals·Jung Hak KimHong Jun Lee
May 7, 2021·Journal of Psychiatric Research·Elżbieta KozłowskaPaulina Żelechowska
May 11, 2021·Neuroscience and Biobehavioral Reviews·Fabrizio MichettiFrancesco Ria
May 20, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Giorgia GasparroniDiego Gazzolo
Dec 19, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Iliana BersaniDiego Gazzolo
Jul 5, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Peng ZengQing Tian
Sep 3, 2021·Neuroscience and Biobehavioral Reviews·Megan E HuibregtseKeisuke Kawata

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Related Papers

European Journal of Pharmacology
Linda NguyenRae R Matsumoto
Clinical Chemistry and Laboratory Medicine : CCLM
Johann SteinerHans-Gert Bernstein
Fundamental & Clinical Pharmacology
Atish PrakashAbu Bakar A Majeed
© 2022 Meta ULC. All rights reserved